General Information of This Linker
Linker ID
LIN0FZQTM
Linker Name
DBCO-Val-Cit-PABC
Linker Type
Cathepsin-cleavable linker
Antibody-Linker Relation
Cleavable
Structure
Formula
C37H42N6O6
Isosmiles
OCC1=CC=C(C=C1)NC([C@@H](NC([C@H](C(C)C)NC(CCC(N2CC3=CC=CC=C3C#CC4=CC=CC=C42)=O)=O)=O)CCCNC(N)=O)=O
InChI
InChI=1S/C37H42N6O6/c1-24(2)34(36(48)41-30(11-7-21-39-37(38)49)35(47)40-29-17-13-25(23-44)14-18-29)42-32(45)19-20-33(46)43-22-28-10-4-3-8-26(28)15-16-27-9-5-6-12-31(27)43/h3-6,8-10,12-14,17-18,24,30,34,44H,7,11,19-23H2,1-2H3,(H,40,47)(H,41,48)(H,42,45)(H3,38,39,49)/t30-,34-/m0/s1
InChIKey
DSBPSTFXGYLDAW-NHZFLZHXSA-N
Pharmaceutical Properties
Molecule Weight
666.779
Polar area
182.96
Complexity
1677.467863
xlogp Value
2.9183
Heavy Count
49
Rot Bonds
14
Hbond acc
6
Hbond Donor
6
Each Antibody-drug Conjugate Related to This Linker
Full Information of The Activity Data of The ADC(s) Related to This Linker
IN202417103159A 2188-D04-Yl80/F404/K42/E161-LP1 [Investigative]
Revealed Based on the Cell Line Data
Click To Hide/Show 2 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal Effective Concentration (EC50)
0.022 nM
Positive ROR1 expression (ROR1+++/++)
Method Description
The cell killing EC5o and Span for RORI ADCs conjugated to different linker warheads at different DARs on RORI positive Ntera-2 cell and RORI negative MCF-7 cells
In Vitro Model Embryonal carcinoma Ntera-2 cells CVCL_0034
Experiment 2 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal Effective Concentration (EC50) > 10 nM Negative ROR1 expression (ROR1-)
Method Description
The cell killing EC5o and Span for RORI ADCs conjugated to different linker warheads at different DARs on RORI positive Ntera-2 cell and RORI negative MCF-7 cells
In Vitro Model Invasive breast carcinoma MCF-7 cells CVCL_0031
IN202417103159A 2188-D04-Yl80/F404/K42-LP1 [Investigative]
Revealed Based on the Cell Line Data
Click To Hide/Show 2 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal Effective Concentration (EC50)
0.082 nM
Positive ROR1 expression (ROR1+++/++)
Method Description
The cell killing EC5o and Span for RORI ADCs conjugated to different linker warheads at different DARs on RORI positive Ntera-2 cell and RORI negative MCF-7 cells
In Vitro Model Embryonal carcinoma Ntera-2 cells CVCL_0034
Experiment 2 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal Effective Concentration (EC50) > 10 nM Negative ROR1 expression (ROR1-)
Method Description
The cell killing EC5o and Span for RORI ADCs conjugated to different linker warheads at different DARs on RORI positive Ntera-2 cell and RORI negative MCF-7 cells
In Vitro Model Invasive breast carcinoma MCF-7 cells CVCL_0031
IN202417103159A 2188-D04-Yl80/F404-LP1 [Investigative]
Revealed Based on the Cell Line Data
Click To Hide/Show 2 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal Effective Concentration (EC50) > 10 nM Negative ROR1 expression (ROR1-)
Method Description
The cell killing EC5o and Span for RORI ADCs conjugated to different linker warheads at different DARs on RORI positive Ntera-2 cell and RORI negative MCF-7 cells
In Vitro Model Invasive breast carcinoma MCF-7 cells CVCL_0031
Experiment 2 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal Effective Concentration (EC50) > 10 nM Positive ROR1 expression (ROR1+++/++)
Method Description
The cell killing EC5o and Span for RORI ADCs conjugated to different linker warheads at different DARs on RORI positive Ntera-2 cell and RORI negative MCF-7 cells
In Vitro Model Embryonal carcinoma Ntera-2 cells CVCL_0034
References
Ref 1 Anti-ROR1 antibodies and antibody conjugates, compositions comprising Anti-ROR1 antibodies or antibody conjugates, and methods of making and using Anti-ROR1 antibodies and antibody conjugates